IL6 and neoplasm: Six out of 18 chemokines/cytokines assessed were significantly decreased in the ascites from NLRC5+ tumor-bearing mice (Figure 6D), including IL-6, IL-10, IL-12, CXCL10, CCL5, and to a greater extent, CCL2.